Medident SPRL
Medident reported total assets of 185,879 € at the end of the 2025 financial year (annual accounts filed with the NBB on 29 Jan 2026).
The score of Medident shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -88 % Total assets +37 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Medident's annual accounts
Filed annual accounts
- Year ended 30 Jun 2025filed on 29 Jan 2026
- Year ended 30 Jun 2024filed on 31 Jan 2025
- Year ended 30 Jun 2023filed on 30 Jan 2024
- Year ended 30 Jun 2022filed on 30 Jan 2023
- Year ended 30 Jun 2021filed on 30 Nov 2021
Medident's financial analysis
- Solvency1.4%sector median: 45.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Medident
Medident's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0674.755.457
- VAT number
- BE0674755457
- Peppol
- Registered · 0208:0674755457 · as of 10 Nov 2026
- Legal form
- SPRL
- Incorporated
- 24 Apr 2017
- Registered office
- 9600 Ronse
- Latest accounts
- 2025 · filed on 29 Jan 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Medident (SPRL) has been based in Ronse since 2017, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net loss of 9,467 € and equity of 2,628 €; its revenue is not published. Its solvency stands at 1.4%, below the median of its sector (45.8%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Medident
Companies in the same business, of comparable size and area, outside its group.
- Honeypatch Manufacture of pharmaceutical preparations Liège · balance sheet 330,409 €
- Pharmaceutical industries Advice Wholesale of pharmaceutical and medical goods Rixensart · balance sheet 27,340 €
- RMS Evolution Wholesale of pharmaceutical and medical goods Roosdaal · balance sheet 164,586 €
- Loedco Wholesale of pharmaceutical and medical goods Alveringem · balance sheet 383,590 €
- Motron Wholesale of pharmaceutical and medical goods Aartselaar · balance sheet 169,630 €
- Adocs Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet 717,403 €
- Added Pharma International Wholesale of pharmaceutical and medical goods Schoten · balance sheet 308,424 €
- AM4Dentists Wholesale of pharmaceutical and medical goods Ostend · balance sheet 116,737 €
Frequently asked questions about Medident
What is the revenue of Medident?
Medident files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Medident?
In Belgium, the VAT number is the company number prefixed with BE: BE0674755457 for Medident, if the company is VAT-registered. Its company number (CBE) is 0674.755.457.
Where is the registered office of Medident?
According to the CBE register, the registered office of Medident is in 9600 Ronse.
What is the equity of Medident?
At the close of the 2025 financial year, the equity of Medident amounts to 2,628 €, a solvency of 1.4% of total assets.
Who manages Medident?
The register lists 1 active mandates at Medident. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Medident
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →